Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

NCT02489448 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yale University